Davies, J.A.; Marlow, G.; Uusi-Kerttula, H.K.; Seaton, G.; Piggott, L.; Badder, L.M.; Clarkson, R.W.E.; Chester, J.D.; Parker, A.L.
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20. Viruses 2021, 13, 864.
https://doi.org/10.3390/v13050864
AMA Style
Davies JA, Marlow G, Uusi-Kerttula HK, Seaton G, Piggott L, Badder LM, Clarkson RWE, Chester JD, Parker AL.
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20. Viruses. 2021; 13(5):864.
https://doi.org/10.3390/v13050864
Chicago/Turabian Style
Davies, James A., Gareth Marlow, Hanni K. Uusi-Kerttula, Gillian Seaton, Luke Piggott, Luned M. Badder, Richard W. E. Clarkson, John D. Chester, and Alan L. Parker.
2021. "Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20" Viruses 13, no. 5: 864.
https://doi.org/10.3390/v13050864
APA Style
Davies, J. A., Marlow, G., Uusi-Kerttula, H. K., Seaton, G., Piggott, L., Badder, L. M., Clarkson, R. W. E., Chester, J. D., & Parker, A. L.
(2021). Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20. Viruses, 13(5), 864.
https://doi.org/10.3390/v13050864
